<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240718062454N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-08-01</date_registration>
      <primary_sponsor>Rasht University of Medical Sciences</primary_sponsor>
      <public_title>"Investigating Intra-abdominal Pressures on Elderly Patients during Elective Laparoscopic Cholecystectomy"</public_title>
      <acronym></acronym>
      <scientific_title>"Comparison of the Effect of Intrَa-Abdominal Pressure on Hemodynamic Parameters and Cerebral Oxygenation during Elective Laparoscopic Cholecystectomy in Elderly Patients under General Anesthesia ; A Double Blind Clinical Trial Study"</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-09-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>31</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/78026</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients are assigned to two groups of high intra-abdominal pressure (13-15 mm Hg) and low intra-abdominal pressure (10-12 mm Hg) using the random sequence created in blocks of four by WinPepi software. Allocation concealment will be used for concealment. This method is used to implement the random sequence of participants in the study. So that before assigning the individual, the assigned group is not specified. In this method, using identical sealed envelopes, with a random sequence, in this method, each of the random sequences created is recorded on a card, and the cards are placed inside the envelopes in order. In order to maintain the random sequence, the outer surface of the envelopes is numbered in the same order. At the time of placement of eligible patients for the study on the bed of the operating room, one of the envelopes is opened by the surgical technician responsible for adjusting the pressure of the laparoscope and placed in one of the two groups of high and low intra-abdominal pressure based on the pressure recorded in the patient card. Patients will be randomized with the help of four random blocks created by the computer (Win Pepi 11.65 software) by an experienced surgical technician who is not a collaborator of the project through the list of eligible patients who have given informed consent and the sequence of randomization blocks to 1:1 ratio are assigned to one of the two groups of high intra-abdominal pressure (13-15 mm Hg) and low intra-abdominal pressure (10-12 mm Hg), Blinding description: This study is double-blind. The surgeon and the anesthesiologist, who is responsible for evaluating and collecting data, will be unaware of the intra-abdominal pressure applied to the patient, and the adjustment of the intra-abdominal pressure will be performed by an experienced surgical technician who is not a member of the project. . The anesthesiologist in charge of the patient will be informed about the treatment groups in order to take the necessary measures in case of complications. In order to blind the surgeon, the intra-abdominal pressure monitor of the laparoscope device is placed outside the view of the surgeon and exposed to the view of the surgical technician responsible for adjusting the patient's intra-abdominal pressure.</study_design>
      <phase>3</phase>
      <hc_freetext>Condition 1: Intraabdominal pressure. Condition 2: Hemodynamic parameters. Condition 3: cerebral oxygenation. Condition 4: Elective laparoscopic cholecystectomy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: High intra-abdominal pressure (13-15 mmHg). Intervention 2: Intervention group: High intra-abdominal pressure (13-15 mmHg).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Samane Ghazanfar Tehran</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Namjoo Street, Rasht</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4144654839</zip>
        <telephone>+98 13 3336 9823</telephone>
        <email>Tehranisamaneh88rasht@gmail.com</email>
        <affiliation>Rasht University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Samaneh Ghazanfar Tehran</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>رشت، خیابان نامجو، بیمارستان الزهرا، مرکز تحقیقات بیهوشی</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4144654839</zip>
        <telephone>+98 13 3336 9823</telephone>
        <email>Tehranisamaneh88rasht@gmail.com</email>
        <affiliation>Rasht University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Elderly patients over 60 years old with ASA class 1-2 are candidates for elective laparoscopic cholecystectomy.</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with cerebrovascular disease (cerebral ischemia or hematoma), neurological disorders (dementia, seizures, Parkinson's and Alzheimer's), uncontrolled hypertension and diabetes, advanced organ failure (class 3 and 4 heart failure)
Patient refusal to participate in the study
Body mass index above 35 and below 18</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: High intra-abdominal pressure (13-15 mmHg)</i_keyword>
      <i_keyword>Intervention group: High intra-abdominal pressure (13-15 mmHg)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The amount of brain oxygen of patients. Timepoint: In the awake state (T0), 5 minutes after induction of anesthesia and intubation before Blowing gas into the abdomen (T1) and then 5 minutes after blowing gas into the abdomen (T2), 15 minutes after blowing gas into the abdomen (T3), immediately after gas exit and changing the horizontal position (T5) And it will be recorded 15 minutes after the exit of gas (T6). Method of measurement: It will be measured based on the cerebral oxygenation percentage listed in the patient's monitoring.</prim_outcome>
      <prim_outcome>Systolic, diastolic and mean arterial blood pressure. Timepoint: In the awake state (T0), 5 minutes after induction of anesthesia and intubation before Blowing gas into the abdomen (T1) and then 5 minutes after blowing gas into the abdomen (T2), 15 minutes after blowing gas into the abdomen (T3), immediately after gas exit and changing the horizontal position (T5) And it will be recorded 15 minutes after the exit of gas (T6). Method of measurement: Based on the blood pressure listed in the patient's monitoring, it will be measured in millimeters of mercury.</prim_outcome>
      <prim_outcome>The patient's heart rate. Timepoint: In the awake state (T0), 5 minutes after induction of anesthesia and intubation before blowing gas into the abdomen (T1) and then 5 minutes after blowing gas into the abdomen (T2), 15 minutes after blowing gas into the abdomen Abdomen (T3) will be recorded immediately after passing gas and changing the horizontal position (T5) and 15 minutes after passing gas (T6). Method of measurement: It will be measured based on the number of beats listed in the patient's monitoring based on the number of heart beats per minute.</prim_outcome>
      <prim_outcome>Oxygen saturation of arterial blood of patients. Timepoint: In the awake state (T0), 5 minutes after induction of anesthesia and intubation before blowing gas into the abdomen (T1) and then 5 minutes after blowing gas into the abdomen (T2), 15 minutes after blowing gas into the abdomen Abdomen (T3) will be recorded immediately after passing gas and changing the horizontal position (T5) and 15 minutes after passing gas (T6). Method of measurement: It will be measured based on the arterial oxygenation percentage listed in the patient monitoring.</prim_outcome>
      <prim_outcome>End-expiratory carbon dioxide. Timepoint: In the awake state (T0), 5 minutes after induction of anesthesia and intubation before blowing gas into the abdomen (T1) and then 5 minutes after blowing gas into the abdomen (T2), 15 minutes after blowing gas into the abdomen Abdomen (T3) will be recorded immediately after passing gas and changing the horizontal position (T5) and 15 minutes after passing gas (T6). Method of measurement: Based on the exhaled carbon dioxide listed in the patient's monitoring, it will be measured in millimeters of mercury.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Investigation of complications and outcome of patients in recovery in two groups of high intra-abdominal pressure (13-15 mm Hg) and low intra-abdominal pressure (10-12 mm Hg). Timepoint: After surgery. Method of measurement: The presence of nausea, vomiting/hemorrhage/pneumothorax/loss of saturation/increase or decrease in blood pressure will be measured in patients.</sec_outcome>
      <sec_outcome>Satisfaction of the surgeon. Timepoint: After surgery. Method of measurement: Based on the 5-point Likert scale, it will be measured as very poor/poor/satisfactory/good/excellent.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Rasht University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-06-26</approval_date>
        <contact_name>Ethics committee of Guilan University of Medical Sciences</contact_name>
        <contact_address>Anesthesiology Research Center ,  Alzahra Hospital, Guilan University of Medical Sciences, Namjoo Street, Rasht, Iran Rasht Guilan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
